Guides duration of Dual Antiplatelet Therapy
Total Score
Score < 2: Unfavorable risk/benefit for prolonged DAPT. Bleeding risk outweighs ischemic benefit. Consider 12 months only.
Disclaimer: The clinical scoring and algorithms on this platform are intended strictly for professional informational purposes. They do not constitute a definitive medical diagnosis, treatment, or clinical decision. The final judgment and responsibility lie with the treating physician.
Yasal Uyarı: Bu platformdaki klinik skorlamalar ve algoritmalar yalnızca sağlık profesyonellerini bilgilendirme amaçlıdır. Herhangi bir kesin tıbbi teşhis, tedavi veya klinik karar yerine geçemez. Nihai karar ve sorumluluk hastayı yatak başında değerlendiren hekime aittir.
The DAPT (Dual Antiplatelet Therapy) score assesses the ischemic versus bleeding risk in patients who have completed 12 months of DAPT without a bleeding or ischemic event following coronary stent placement. A high score (≥2) suggests that the benefit of preventing ischemic events (MI, stent thrombosis) outweighs the bleeding risk of prolonged therapy.
Age is inversely weighted in the DAPT score. Older patients (especially ≥75 years) receive negative points because their risk of major, life-threatening bleeding with prolonged DAPT often overshadows the marginal reduction in stent thrombosis.
Yeh RW, Secemsky EA, Kereiakes DJ, et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735-1749.
Disclaimer: The clinical scoring and algorithms on this platform are intended strictly for professional informational purposes. They do not constitute a definitive medical diagnosis, treatment, or clinical decision. The final judgment and responsibility lie with the treating physician.